Does OSIMERTINIB Cause Pericardial effusion? 113 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Pericardial effusion have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.4% of all adverse event reports for OSIMERTINIB.
113
Reports of Pericardial effusion with OSIMERTINIB
0.4%
of all OSIMERTINIB reports
17
Deaths
65
Hospitalizations
How Dangerous Is Pericardial effusion From OSIMERTINIB?
Of the 113 reports, 17 (15.0%) resulted in death, 65 (57.5%) required hospitalization, and 12 (10.6%) were considered life-threatening.
Is Pericardial effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Pericardial effusion?
TREPROSTINIL (584)
IBRUTINIB (467)
CYCLOPHOSPHAMIDE (458)
NIVOLUMAB (454)
METHOTREXATE (412)
MACITENTAN (407)
DASATINIB (388)
ADALIMUMAB (374)
AMBRISENTAN (371)
PEMBROLIZUMAB (362)
Which OSIMERTINIB Alternatives Have Lower Pericardial effusion Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN